EAM
ATRA icon

Eagle Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Eagle Asset Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-67,486
Closed -$14.4M – 565
2020
Q1 		$14.4M Buy
67,486
+2,631
+4% +$835K 0.09% 232
2019
Q4 		$26.7M Sell
64,855
-551
-0.8% -$190K 0.13% 216
2019
Q3 		$23.1M Buy
65,406
+1,228
+2% +$458K 0.12% 219
2019
Q2 		$32.3M Buy
64,178
+2,508
+4% +$1.77M 0.17% 204
2019
Q1 		$61.3M Sell
61,670
-2,718
-4% -$2.53M 0.33% 125
2018
Q4 		$55.9M Sell
64,388
-610
-0.9% -$567K 0.35% 111
2018
Q3 		$67.2M Buy
64,998
+6,568
+11% +$6.42M 0.32% 115
2018
Q2 		$53.7M Sell
58,430
-1,033
-2% -$1.11M 0.29% 136
2018
Q1 		$58M Sell
59,463
-11
-0% -$10K 0.32% 112
2017
Q4 		$28.7M Sell
59,474
-129
-0.2% -$47.6K 0.16% 210
2017
Q3 		$25.8M Sell
59,603
-116
-0.2% -$43.7K 0.15% 230
2017
Q2 		$20.9M Buy
59,719
+9,015
+18% +$3.47M 0.13% 230
2017
Q1 		$26M Buy
50,704
+6,276
+14% +$2.6M 0.16% 187
2016
Q4 		$15.8M Buy
44,428
+5,201
+13% +$2.2M 0.1% 265
2016
Q3 		$21M Buy
39,227
+323
+0.8% +$175K 0.14% 211
2016
Q2 		$21.9M Sell
38,904
-2,136
-5% -$1.03M 0.15% 197
2016
Q1 		$19.5M Buy
41,040
+6,904
+20% +$3.11M 0.14% 219
2015
Q4 		$22.5M Buy
34,136
+11,639
+52% +$8.8M 0.15% 200
2015
Q3 		$17.7M Buy
+22,497
New +$27.4M 0.12% 229

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Eagle Asset Management's ATRA Position: Q2 2020 in Review

Eagle Asset Management sold out of Atara Biotherapeutics (ATRA) in Q2 2020, closing a stake of 67,486 shares — an estimated $14.4M sold.

Eagle Asset Management first reported a position in ATRA in Q3 2015 and held it in 19 quarters. The position peaked at $67.2M in Q3 2018. 122 funds tracked by Wall St. Rank hold ATRA as of Q2 2020.

  • Eagle Asset Management reported no remaining Atara Biotherapeutics position as of Q2 2020 after selling out during the quarter.
  • Eagle Asset Management sold 67,486 Atara Biotherapeutics shares in Q2 2020, an estimated $14.4M.
  • Eagle Asset Management first reported a position in Atara Biotherapeutics in Q3 2015 and held it in 19 quarters.
  • Eagle Asset Management's Atara Biotherapeutics position peaked at $67.2M in Q3 2018.
  • 122 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2020.

Based on Eagle Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.